Skip to main content
Caplight Logo









OncoRes Medical

OncoRes Medical

Private
NedlandsHealthcare & Life Scienceshttps://oncoresmedical.com

Last Round

VC Round

Feb 12, 2026

Total Funding Raised

$20.77M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

OncoRes Medical operates in Healthcare & Life Sciences and is based in Nedlands. Its latest recorded funding round was a VC Round in February 2026.

OncoRes Medical is a medical device company developing a handheld, real-time, intraoperative imaging device to improve the detection of residual tumors during breast-conserving surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

OncoRes Medical Comparables

Compare OncoRes Medical with similar companies based on industry and business-model similarity.

OncoRes Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Perimeter Medical Imaging AI Inc
86%
Lumicell, Inc.
85%
Dilon Technologies Inc.
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

OncoRes Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 12, 2026
GrantJul 18, 2023
Series A ExtensionMay 18, 2022
GrantMay 18, 2022
GrantJan 22, 2021
Grant
Dec 18, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Katharine Giles

Managing Director CEO

Executive Team

Simon Graindorge

Chief Operating Officer

Executive Team

For institutional investors. Book with your work email.

OncoRes Medical Investors

Notable investors and investment history

Book a demo to see all 8 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors increased 145% MoM.

  • Apr 16, 2026

    Monthly visitors grew 1252% MoM, reaching 4.7K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • receives_awardOct 23, 2026

    OncoRes Medical Pty Ltd, an Australia-based medical technology company, receives a nomination for the 2026 Prix Galien USA Awards in the Best Startup category in Oct '26 for its work helping surgeons identify microscopic cancer tissue in real time.

  • receives_awardAug 15, 2026

    Currently in clinical trials, OncoRes Medical Pty Ltd is one of three Australian organisations shortlisted for an international award dubbed the Nobel Prize of Life Sciences in Western Australia on Aug 15th '26.

  • recognized_asAug 13, 2026

    The Prix Galien USA Awards nominate OncoRes Medical Pty Ltd, an Australian cancer-surgery imaging company, in the Best Startup category.

  • recognized_asAug 13, 2026

    On Aug 14th '26, Western Australia-based OncoRes Medical Pty Ltd is nominated by the Prix Galien USA Awards in the Best Startup category, recognizing its cancer-surgery imaging innovation.

  • recognized_asAug 13, 2026

    OncoRes Medical Pty Ltd is named a finalist for a Prix Galien Award, becoming the first Western Australian finalist for an award widely regarded as the Nobel Prize equivalent for the life sciences sector.

Book a demo to see all news

For institutional investors. Book with your work email.

OncoRes Medical Filings

Explore SEC and related filing metadata, where available.

OncoRes Medical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about OncoRes Medical's valuation, stock price, and market status.

Is OncoRes Medical a public or private company?

OncoRes Medical is a private company.

What is the current stock price of OncoRes Medical?

OncoRes Medical is a private company, so its shares have no public market price. Caplight tracks OncoRes Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is OncoRes Medical worth (valuation)?

Valuation information for OncoRes Medical is not publicly available.

Can I buy OncoRes Medical stock?

OncoRes Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was OncoRes Medical's last funding round?

OncoRes Medical's most recent funding round was VC Round on February 12, 2026.

Who are the main investors in OncoRes Medical?

Key investors in OncoRes Medical include Brandon Capital.

Will OncoRes Medical IPO soon?

No public IPO plans have been announced for OncoRes Medical.

How can I track OncoRes Medical secondary market activity?

Caplight tracks bids, offers, and trades in OncoRes Medical's shares on secondary markets.

Firmographic Details

HeadquartersNedlands
Employee Range38
Year Founded2016
Last FundingFeb 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?